Kassubek, J, Factor, SA, Balaguer, E, Schwarz, J, Chaudhuri, KR, Isaacson, SH, Wu, S, Muhr, CD, Kulisevsky, J. Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study. JOURNAL OF NEUROLOGY. 2024; 271(6)DOI:10.1007/s00415-024-12323-2. PMID:38546829. IF:4.600(Q1/2D).

Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Sampedro, F, Horta-Barba, A, Campolongo, A, Rivas-Asensio, E, Puig-Davi, A, Pagonabarraga, J, Kulisevsky, J. Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease. Annals of Clinical and Translational Neurology. 2024; 11(5)DOI:10.1002/acn3.52031. PMID:38544341. IF:3.900(Q1/3D).

Garon, M, Weis, L, Siquier, A, Fiorenzato, E, Pistonesi, F, Cianci, V, Canesi, M, Pesce, F, Reali, E, Pozzi, B, Isaias, IU, Siri, C, Santangelo, G, Cuoco, S, Barone, P, Kulisevsky, J, Antonini, A, Biundo, R. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(4)DOI:10.1007/s00702-024-02746-6. PMID:38280057. IF:4.000(Q1/2D).

Pagonabarraga, J, Bejr-Kasem, H, Martinez-Horta, S, Kulisevsky, J. Parkinson disease psychosis: from phenomenology to neurobiological mechanisms. Nature Reviews Neurology. 2024; 20(3)DOI:10.1038/s41582-023-00918-8. PMID:38225264. IF:33.100(Q1/1D).

Ruiz-Barrio, I, Horta-Barba, A, Aracil-Bolaños, I, Martinez-Horta, S, Kulisevsky, J, Pagonabarraga, J. Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe Signs. Movement Disorders Clinical Practice. 2024; 11(3)DOI:10.1002/mdc3.13958. PMID:38164060. IF:2.700(Q2/5D).

Aracil-Bolaños, I, Pérez-Pérez, J, Martínez-Horta, S, Horta-Barba, A, Puig-Davi, A, Garcia-Cornet, J, Olmedo-Saura, G, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Baseline Large-Scale Network Dynamics Associated with Disease Progression in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(1)DOI:10.1002/mds.29655. PMID:38148511. IF:7.600(Q1/1D).

Rodríguez-Antigüedad J., Martínez-Horta S., Horta-Barba A., Puig-Davi A., Campolongo A., Sampedro F., Bejr-Kasem H., Marín-Lahoz J., Pagonabarraga J., Kulisevsky J.. Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(12)DOI:10.1007/s00702-023-02725-3. PMID:38206439. IF:4.000(Q1/2D).

Cattaneo, C, Kulisevsky, J. The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson's Disease. ADVANCES IN THERAPY. 2023; DOI:10.1007/s12325-023-02736-2. PMID:38070039. IF:3.400(Q2/3D).

Santos-García, D, Fonticoba, TD, Bartolomé, CC, Painceiras, MJF, Díaz, IG, Alvarado, MCI, Paz, JM, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordás, C, Menéndez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P, COPPADIS Study Grp. Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden. Brain and Behavior. 2023; 13(12)DOI:10.1002/brb3.3295. PMID:37939322. IF:2.600(Q2/3D).

Constantin VA, Szász JA, Dulamea AO, Valkovic P, Kulisevsky J. Impact of Infusion Therapies on Quality of Life in Advanced Parkinson's Disease.. Neuropsychiatric Disease and Treatment. 2023; 19DOI:10.2147/NDT.S422717. PMID:37727253. IF:2.500(Q2/5D).

Santos-García D., Cores Bartolomé C., Feal Painceiras M.J., García Díaz I., Íñiguez Alvarado M.C., Paz J.M., García Caldentey J., Hernández Vara J., Cabo I., López Manzanares L., González Aramburu I., Ávila Rivera M.A., Gómez Mayordomo V., Dotor García-Soto J., Borrué C., Solano Vila B., Álvarez Sauco M., Mendoza Z., Martínez Castrillo J.C., Sánchez Alonso P., Alonso Losada M.G., López Ariztegui N., Alonso Redondo R., Menéndez-González M., Adarmes A.D., Almeria M., Losada M.G.A., Cánovas A.A., Frech F.A., Redondo R.A., Álvarez I., Sauco M.Á., Díaz A.A., Arnáiz S., Arribas S., Vidondo A.A., Aguilar M., Ávila M.A., Lambrich N.N., Bejr-Kasem H., Estrada M.B., Botí M., Borrue C., Buongiorno M.T., González C.C., López I.C., Caballol N., Lorenzo A.C., Medina H.C., Pendón E.C., Carrillo F., Padilla F.J.C., Casas E., Catalán M.J., Clavero P., Fernández A.C., Cosgaya M., Foraster A.C., Cuevas A.C., Cubo E., de Deus Fonticoba T., de Fábregues-Boixar O., Díez-Fairen M., García-Soto J.D., Erro E., Escalante S., Peyret E.E., Guillán N.F., Gámez P., Gallego M., Caldentey J.G., Campos C.G., Díez C.G., Moreno J.M.G., Gastón I., Garre M.P.G., Mayordomo V.G., Aloy J.G., González-Aramburu I., Ardura J.G., García B.G., Palmás M.J.G., Toledo G.R.G., Díaz A.G., Solá M.G., Guardia G., Vara J.H., Horta-Barba A., Calderón D.I., Infante J., Jesús S., Kulisevsky J., Kurtis M., Labandeira C., Labrador M.A., Lacruz F., Castro M.L., Gómez S.L., Legarda I., Ariztegui N.L., Díaz L.M.L., Domínguez D.L., Manzanares L.L., Seoane B.L., del Pozo S.L., Macías Y., Mata M., Andres G.M., Martí M.J., Castrillo J.C.M., Martinez-Martin P., McAfee D., Meitín M.T., Plasencia Z.M., González M.M., del Barrio C.M., Mir P., Santiago J.M., Casado M.I.M., Diéguez A.M., García I.M., Nogueira V., Amado A.N., Ponte S.N., Ordás C., Pagonabarraga J., Pareés I., Pascual-Sedano B., Pastor P., Fuertes A.P., Noguera R.P., Planas-Ballvé A., Planellas L., Prats M.A., Jurczynska C.P., Puente V., Morlans M.P., Daví A.P., Rafales N.R., Méndez L.R., Pérez A.B.R., Roldán F., De Arcos M.R., Martínez J.R., Alonso P.S., Sánchez-Carpintero M., Díez G.S., Rodríguez A.S., Santacruz P., García D.S., Rodríguez J.C.S., Seijo M., Peña M.S., Vila B.S., Castro E.S., Tartari J.P., Valero C., Vargas L., Vela L., Villanueva C.. Cognitive impairment and dementia in young onset Parkinson’s disease. JOURNAL OF NEUROLOGY. 2023; DOI:10.1007/s00415-023-11921-w. PMID:37578489. IF:4.800(Q1/2D).

Horta-Barba, A, Martinez-Horta, S, Perez-Perez, J, Puig-Davi, A, de Lucia, N, de Michele, G, Salvatore, E, Kehrer, S, Priller, J, Migliore, S, Squitieri, F, Castaldo, A, Mariotti, C, Mananes, V, Lopez-Sendon, JL, Rodriguez, N, Martinez-Descals, A, Julio, F, Januaario, C, Delussi, M, de Tommaso, M, Noguera, S, Ruiz-Idiago, J, Sitek, EJ, Wallner, R, Nuzzi, A, Pagonabarraga, J, Kulisevsky, J. Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instruments. JOURNAL OF NEUROLOGY. 2023; 270(11)DOI:10.1007/s00415-023-11804-0. PMID:37462754. IF:4.800(Q1/2D).

Olszewska, DA, Shetty, A, Rajalingam, R, Rodriguez-Antiguedad, J, Hamed, M, Huang, JA, Breza, M, Rasheed, A, Bahr, N, Madoev, H, Westenberger, A, Trinh, J, Lohmann, K, Klein, C, Marras, C, Waln, O. Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(10)DOI:10.1111/ene.15969. PMID:37422902. IF:4.500(Q1/2D).

Kulisevsky J., Falup-Pecurariu C., Santens P., Jost W.H.. Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines. JOURNAL OF NEURAL TRANSMISSION. 2023; 130(11)DOI:10.1007/s00702-023-02664-z. PMID:37439943. IF:3.200(Q2/3D).

Collerton, D, Barnes, J, Diederich, NJ, Dudley, R, Ffytche, D, Friston, K, Goetz, CG, Goldman, JG, Jardri, R, Kulisevsky, J, Lewis, SJG, Naral, S, O'Callaghan, C, Onofrj, M, Pagonabarraga, J, Parr, T, Shine, JM, Stebbins, G, Taylor, JP, Tsuda, I, Weil, RS. Understanding visual hallucinations: A new synthesis. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2023; 150DOI:10.1016/j.neubiorev.2023.105208. PMID:37141962. IF:7.600(Q1/1D).

Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Gonzalez, JMP, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LMLL, McAfee, D, Martinez-Martin, P, Mir, P. Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints. Journal of Clinical Neurology. 2023; 19(4)DOI:10.3988/jcn.2022.0186. PMID:36647231. IF:3.000(Q2/4D).

Collet-Vidiella, R, Olmedo-Saura, G, Ruiz-Barrio, I, Martinez-Viguera, A, Rodriguez-Santiago, B, Bernal, S, Kulisevsky, J, Pagonabarraga, J. Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 2023; 10(8)DOI:10.1002/mdc3.13811. PMID:37635772. IF:2.600(Q2/5D).

Gironell, A. Essential tremor: are we just splitting hairs? Non-motor symptoms and essential tremor-plus. REVISTA DE NEUROLOGIA. 2023; 76(12)DOI:10.33588/rn.7612.2023083. PMID:37303101. IF:0.800(Q4/9D).

Horta-Barba A., Martinez-Horta S., Sampedro F., Pérez-Pérez J., Pagonabarraga J., Kulisevsky J.. Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease. JOURNAL OF NEUROSCIENCE RESEARCH. 2023; 101(6)DOI:10.1002/jnr.25174. PMID:36807154. IF:2.900(Q2/5D).

Gamez, J, Calopa, M, Munoz, E, Ferre, A, Huertas, O, McAllister, K, Reig, N, Scart-Gres, C, Insa, R, Kulisevsky, J. A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2023; 89(5)DOI:10.1111/bcp.15635. PMID:36494329. IF:3.100(Q2/4D).